关注
Chris Orvig
Chris Orvig
Professor of Chemistry and Pharmaceutical Sciences
在 chem.ubc.ca 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Metallodrugs in medicinal inorganic chemistry
KD Mjos, C Orvig
Chemical reviews 114 (8), 4540-4563, 2014
13142014
Matching chelators to radiometals for radiopharmaceuticals
EW Price, C Orvig
Chemical Society Reviews 43 (1), 260-290, 2014
9822014
Vanadium compounds as insulin mimics
KH Thompson, JH McNeill, C Orvig
Chemical reviews 99 (9), 2561-2572, 1999
8441999
Medicinal inorganic chemistry: introduction
C Orvig, MJ Abrams
Chemical Reviews 99 (9), 2201-2204, 1999
7441999
Biosorbents for hexavalent chromium elimination from industrial and municipal effluents
B Saha, C Orvig
Coordination Chemistry Reviews 254 (23-24), 2959-2972, 2010
6592010
Vanadium in diabetes: 100 years from Phase 0 to Phase I
KH Thompson, C Orvig
Journal of inorganic biochemistry 100 (12), 1925-1935, 2006
6112006
Vanadium treatment of type 2 diabetes: a view to the future
KH Thompson, J Lichter, C LeBel, MC Scaife, JH McNeill, C Orvig
Journal of inorganic biochemistry 103 (4), 554-558, 2009
6072009
Bis (maltolato) oxovanadium (IV) is a potent insulin mimic
JH McNeill, VG Yuen, HR Hoveyda, C Orvig
Journal of medicinal chemistry 35 (8), 1489-1491, 1992
4991992
Boon and bane of metal ions in medicine
KH Thompson, C Orvig
Science 300 (5621), 936-939, 2003
4962003
Radioactive main group and rare earth metals for imaging and therapy
TI Kostelnik, C Orvig
Chemical reviews 119 (2), 902-956, 2018
3952018
Design of targeting ligands in medicinal inorganic chemistry
T Storr, KH Thompson, C Orvig
Chemical Society Reviews 35 (6), 534-544, 2006
3912006
Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease
LE Scott, C Orvig
Chemical Reviews 109 (10), 4885-4910, 2009
3832009
Coordination chemistry of vanadium in metallopharmaceutical candidate compounds
KH Thompson, C Orvig
Coordination Chemistry Reviews 219, 1033-1053, 2001
3792001
Reaction chemistry of BMOV, bis (maltolato) oxovanadium (IV), a potent insulin mimetic agent
C Orvig, P Caravan, L Gelmini, N Glover, FG Herring, H Li, JH McNeill, ...
Journal of the American Chemical Society 117 (51), 12759-12770, 1995
3391995
Tumour targeting with radiometals for diagnosis and therapy
CF Ramogida, C Orvig
Chemical Communications 49 (42), 4720-4739, 2013
2882013
Metal complexes in medicinal chemistry: new vistas and challenges in drug design
KH Thompson, C Orvig
Dalton transactions, 761-764, 2006
2642006
Speciation of aluminum in biological systems
WR Harris, G Berthon, JP Day, C Exley, TP Flaten, WF Forbes, T Kiss, ...
Journal of Toxicology and Environmental Health Part A 48 (6), 543-568, 1996
2511996
Synthesis and characterization of lanthanide [Ln (L)] 2 complexes of N4O3 amine phenol ligands with phenolate oxygen bridges: evidence for very weak magnetic exchange between …
S Liu, L Gelmini, SJ Rettig, RC Thompson, C Orvig
Journal of the American Chemical Society 114 (15), 6081-6087, 1992
2461992
A new class of oxotechnetium (5+) chelate complexes containing a TcON2S2 core
A Davison, AG Jones, C Orvig, M Sohn
Inorganic Chemistry 20 (6), 1629-1632, 1981
2231981
Preparation of oxobis (dithiolato) complexes of technetium (V) and rhenium (V)
A Davison, C Orvig, HS Trop, M Sohn, BV DePamphilis, AG Jones
Inorganic Chemistry 19 (7), 1988-1992, 1980
2141980
系统目前无法执行此操作，请稍后再试。
文章 1–20